[uam_ad id="317182"]

RIO DE JANEIRO, BRAZIL - The Army Pharmaceutical Chemical Laboratory (LQFEx) boosted its chloroquine manufacturing capacity even before confirmation on its effectiveness and the possible risks of using the substance to treat coronavirus infections.

From the outbreak of the pandemic in late February until April 14th, the facility, which has been producing the drug since 2000 to treat malaria, has produced more than 1.2 million tablets, Subscribe to our Premium Membership Plan. Already Subscribed?